Showing results (301-310 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|May 26, 2018
Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in MenSriram Venigalla, Ruben Carmona, David M Guttmann, et al.
JAMA Oncology|May 12, 2017
Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysisDonald A Berry, Shouhao Zhou, Howard Higley, et al.
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.
JAMA Oncology|May 1, 2018
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibScott M Schuetze, Vanessa Bolejack, Dafydd G Thomas, et al.
JAMA Oncology|May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch SyndromeKyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
JAMA Oncology|May 1, 2018
Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and ResectionPatricio M Polanco, Ali A Mokdad, Hong Zhu, et al.
JAMA Oncology|July 29, 2018
Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical TrialManali I Patel, Vandana Sundaram, Manisha Desai, et al.
JAMA Oncology|July 7, 2018
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table ModelNora Pashayan, Steve Morris, Fiona J Gilbert, et al.
JAMA Oncology|July 7, 2018
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical TrialKaren A Autio, Robert Dreicer, Justine Anderson, et al.
JAMA Oncology|June 30, 2018
Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate CancerHoward I Scher, Ryon P Graf, Nicole A Schreiber, et al.
Pageof 161